0.10 USD
▲+0.01+3.60%
盘后 0.10 +1.40%
2026-08-03
市值
$4.50M
市盈率
—
EPS
-0.26
股息率
—
52 周区间
0.08 – 1.84
成交量
3.16M
Beta
—
目标价
—
52W 低 0.0852W 高 1.84
价格走势
公司简介
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinical trial for the treatment of Parkinson’s disease; JNS108, which is in Phase II clinical trial for the treatment of mild cognitive impairment/early Alz...